#SANFPC22 seminar organised by our #privatesector interest group. The first part focused on setting up a specialist family physician #privatepractice. The second part showcased three stories on how #familyphysicians developed their practices to make a difference. #hcsmSA #UHC

No need to announce your departure Winter ! (Winter can never leave the room quietly). Come on spring! gph.is/2k4caIz

“When this province pleads poverty, that it doesn’t have money and resources to run a proper health system, and that it is immigrants that are causing the problems, we have to call that out as an absolute lie. ... It is just unconscionable,” he said.

Long covid - it's a helluva thing theguardian.com/society/2022/o…

“Benn’s out-of-the-box thinking, accessibility to patients, and transparency in the way she worked irked senior male managers and doctors. “. Says it all . Top breast cancer surgeon quits Helen Joseph Hospital,... dailymaverick.co.za/article/2022-1…

This article is one of the more important things I've written. It's about nutrition misinformation. ▶️What it is ▶️How widespread it is ▶️Where it comes from ▶️Why people believe it ▶️How, and how much, it harms us asteriskmag.com/issues/2/read-…

Unpublished topline data from SELECT indicates that in non-diabetic overweight patients, wt loss with a GLP-1 agonist is more than cosmetic & reduces the risk of death/stroke & heart attack by 20%. Time to treat obesity like the complex disease it is rather than a moral failing.

🚨BREAKING: Semaglutide meets primary end-point in SELECT trial—reduces 3-point composite MACE by 20%. All endpoints (CV death, non-fatal MI, non-fatal stroke) supposedly contribute to the demonstration of superiority vs. Placebo.

We haven’t yet seen the actual data but a 20% reduction of cardiovascular events in a 17, 500 participant randomized trial of a GLP-1 anti-obesity drug is a big deal and likely will change the reimbursement landscape (and further promote uptake)

Novo Nordisk reports that semaglutide 2.4 mg reduced cardiovascular events by 20% in ppl with obesity in the SELECT trial. Context: This is the third RCT to show CV event reduction with sema. novonordisk.com/content/nncorp… doi.org/10.1056/NEJMoa… doi.org/10.1056/NEJMoa…

This! 👇🏻

Let's hear Marc Cornier discuss the actions of #GIP and #GLP1 in organs outside of the gut.

Online now! Association learning is impaired in insulin resistance and restored by liraglutide dlvr.it/StrSVw

Weighty Matters: Diet Coke Just As Helpful To Weight Loss As Water When Used In Place Of Sugary Beverages open.substack.com/pub/yonifreedh…

HIV, TB meds without a script — unpacking the Pimart court ruling giving pharmacists the green. dailymaverick.co.za/article/2023-0…

1/ 📣 New from my team in Nature Medicine In a study of 6 million people, we examined risk trajectories of 80 components of Long Covid over 2 years post-infection 📌 Risks remained elevated for many Long Covid conditions even 2 years infection A 🧵 nature.com/articles/s4159…

Interesting - and encouraging -data.

BREAKING: The International Court of Justice determines that South Africa does have standing in its case against Israel

Nazis demanded to know if ‘The Hobbit’ author was Jewish. He responded with a high-class burn. I love Tolkien for this classy reply ! flip.it/qUh9lh

Check out our new Website with information on HIV, Autoimmune disease and general nutrition using the link below! wix.to/DIV6OYy